NASDAQ
Ceryvyn Therapeutics Limited (CKDXF) has a fcf yield of -29.44% as of Monday, August 3, 2026. This represents a 46.13% increase compared to its 12-month average of -54.66%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.